These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17037630)

  • 1. DTC drug ads in the spotlight.
    Guglielmo WJ
    Med Econ; 2006 Sep; 83(18):20. PubMed ID: 17037630
    [No Abstract]   [Full Text] [Related]  

  • 2. Do ads really drive pharmaceutical sales? The true effects of DTC advertising remain a mystery.
    Findlay S
    Mark Health Serv; 2002; 22(1):20-5. PubMed ID: 11881540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dealing with drug advertising. The FDA can't always enforce the rules on misleading ads.
    Atkinson HG
    Health News; 2003 Feb; 9(2):5. PubMed ID: 12632541
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug ads. Some mislead consumers.
    Roberts SS
    Diabetes Forecast; 2003 Oct; 56(10):46-8. PubMed ID: 15317096
    [No Abstract]   [Full Text] [Related]  

  • 5. Who reviews the ads?
    Relman AS
    N Engl J Med; 1979 Nov; 301(18):999. PubMed ID: 492232
    [No Abstract]   [Full Text] [Related]  

  • 6. Turning point or tipping point: new FDA draft guidances and the future of DTC advertising.
    Pitts PJ
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-259-61. PubMed ID: 15452001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
    Waxman HA
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-256-8. PubMed ID: 15452002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
    Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct-to-consumer offers for free and discounted medications on the internet: a content analysis of "e-samples".
    Weppner WG; Hollon MF; Chew LD; Larson EB
    Arch Intern Med; 2009 Nov; 169(21):2024-30. PubMed ID: 19933966
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical advertising as a consumer empowerment device.
    Rubin PH
    J Biolaw Bus; 2001; 4(4):59-65. PubMed ID: 12751498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical ads in journals.
    Liebman M
    Ann Intern Med; 1992 Oct; 117(7):617; author reply 618-9. PubMed ID: 1524341
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceutical ads in journals.
    Beary JF
    Ann Intern Med; 1992 Oct; 117(7):616; author reply 618-9. PubMed ID: 1524338
    [No Abstract]   [Full Text] [Related]  

  • 14. Message strategies in direct-to-consumer pharmaceutical advertising: a content analysis using Taylor's six-segment message strategy wheel.
    Tsai WH; Lancaster AR
    Health Mark Q; 2012; 29(3):239-55. PubMed ID: 22905945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. My stand against DTC ads.
    Bellard BM
    Med Econ; 2004 Feb; 81(4):104. PubMed ID: 15015419
    [No Abstract]   [Full Text] [Related]  

  • 16. What drug price ads must tell.
    Hecht A
    FDA Consum; 1976 Mar; 10(2):18-9. PubMed ID: 828893
    [No Abstract]   [Full Text] [Related]  

  • 17. TV drug ads that make sense.
    Nordenberg T
    FDA Consum; 1998; 32(1):7-10. PubMed ID: 9508552
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessments of pharmaceutical advertisements: a critical analysis of the criticism.
    Beales JH; MacLeod WC
    Food Drug Law J; 1995; 50(3):415-49. PubMed ID: 10343010
    [No Abstract]   [Full Text] [Related]  

  • 19. A look at pharmaceutical ads.
    Salyer D
    Surviv News (Atlanta Ga); 2001 Jul; ():6-7. PubMed ID: 11683018
    [No Abstract]   [Full Text] [Related]  

  • 20. Selling prescription drugs to the consumer: with Vioxx's withdrawal, new questions on a $3.8 billion ad business.
    Elliott S; Ives N
    N Y Times Web; 2004 Oct; ():C1, C9. PubMed ID: 15487065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.